Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways (Q28274882)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways |
scientific article |
Statements
Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways (English)
0 references
20 August 2004
0 references
305
0 references
1163-7
0 references
5687
0 references